رسالة جامعية
Análisis de costo-efectividad del uso de la terapia de presión negativa en el tratamiento del pie diabético
| العنوان: | Análisis de costo-efectividad del uso de la terapia de presión negativa en el tratamiento del pie diabético |
|---|---|
| المؤلفون: | Maloof Roa, Cesar Augusto, Olivares Cerpa, Fánika de Jesús |
| المساهمون: | ALVIS ZAKZUK, NELSON RAFAEL, Universidad de la Costa, Beltrán Venegas, Tulia, Alvis Guzmán, Nelson, Orozco Africano, Julio |
| بيانات النشر: | Corporación Universidad de la Costa Ciencias de la salud Barranquilla Maestría en Gestión de Servicios de Salud |
| سنة النشر: | 2023 |
| المجموعة: | REDICUC - Repositorio Universidad de La Costa |
| مصطلحات موضوعية: | Costo-Efectividad, Análisis, Oxigenoterapia, Úlceras, Diabetes, RCEI |
| جغرافية الموضوع: | Barranquilla |
| الوصف: | Analizar los costos y la efectividad del uso de sistemas de presión negativa comparado con sistemas de oxigenoterapia tópica y nepidermina en el tratamiento de las úlceras de pie diabético en Colombia ; Lista de Tablas y Figuras 9—Introducción 12-- Metodología 19-- Problema de Decisión 19--Población Objeto 19-- Intervención 19—Comparadores 20-- Desenlaces 20-- Pregunta de Evaluación Económica 20-- Horizonte Temporal 20—Perspectiva 21-- Tasa de Descuento 21-- Modelo de Decisión 21-- Diseño 21-- Supuestos del Modelo 24—Probabilidades 24--Desenlaces y Valoración 26-- Identificación, Medición y Valoración de los Costos 28-- Dispositivos y medicamento 29-- Interpretación de Resultados y Análisis de Sensibilidad 31--Resultados 34—Resultados del Caso Base 34-- Análisis de Sensibilidad 35--Discusión38--38 Conclusiones 42--Referencias 43-- Anexos 54-- Anexo 1. Descripción de las Tecnologías y Medicamento Evaluados 54-- Anexo 2. Búsqueda de Literatura Económica 55-- Anexo 3. Bitácora de Búsqueda de Estudios de Calidad de Vida 55-- ; Magíster en Gestión de Servicios de Salud ; Maestría |
| نوع الوثيقة: | master thesis |
| وصف الملف: | 55 páginas; application/pdf |
| اللغة: | Spanish; Castilian |
| العلاقة: | Gordillo GM, Sen CK. Evidence-based recommendations for the use of topical oxygen therapy in the treatment of lower extremity wounds. International Journal of Lower Extremity Wounds. el 14 de junio de 2009;8(2):105–11. IWGDF. Practical guidelines on the prevention and management of diabetes related foot disease. IWGDF 2023 updates [Internet]. [citado el 7 de octubre de 2022]. Disponible en: https://iwgdfguidelines.org/guidelines-2023Test/ Lazarus GS, Cooper DM, Knighton DR, Margolis DJ, Percoraro RE, Rodeheaver G, et al. Definitions and guidelines for assessment of wounds and evaluation of healing. Wound Repair and Regeneration. el 1 de julio de 1994;2(3):165–70. Eaglstein WH, Falanga V. Chronic wounds. Surgical Clinics. el 1 de junio de 1997;77(3):689–700.; Gupta S, Sagar S, Maheshwari G, Kisaka T, Tripathi S. Chronic wounds Magnitude, Socioeconomic Burden and Consequences. Wounds Asia 2021 [Internet]. 2021 [citado el 8 de agosto de 2022];4(1):8–14. Disponible en: www.woundsasia.com; Olsson M, Järbrink K, Divakar U, Bajpai R, Upton Z, Schmidtchen A, et al. The humanistic and economic burden of chronic wounds: A systematic review. Wound Repair and Regeneration. el 1 de enero de 2019;27(1):114–25; Graves N, Phillips CJ, Harding K. A narrative review of the epidemiology and economics of chronic wounds. British Journal of Dermatology. el 1 de agosto de 2022;187(2):141–8.; Cwalinski J, Paszkowski J, Banasiewicz T. New perspectives in the treatment of hard-to-heal wounds. Negative Pressure Wound Therapy Journal. el 22 de diciembre de 2018;5(4):10–2.; Lo SF, Chuang ST, Liao PL. Challenges and dilemmas of providing healthcare to patients in home care settings with hard-to-heal wounds. Journal of Nursing. el 1 de agosto de 2021;68(4):89–95.; Bowers S, Franco E. Chronic Wounds: Evaluation and Management [Internet]. 2020 [citado el 10 de abril de 2022]. Disponible en: https://www.aafp.org/afp/2020/0201/p159.htmlTest; Murray RZ, West ZE, McGuiness W. The multi factorial formation of chronic wounds. Wound Practice & Research: Journal of the Australian Wound Management Association. 2018;26(1):38–46.; Alam W, Hasson J, Reed M. Clinical approach to chronic wound management in older adults. J Am Geriatr Soc. 2021;69(8):2327–34.; Abbade LPF, Frade MAC, Pegas JRP, Dadalti-Granja P, Garcia LC, Bueno Filho R, et al. Consensus on the diagnosis and management of chronic leg ulcers - Brazilian Society of Dermatology. An Bras Dermatol. el 24 de marzo de 2021;95(S1):1–18.; Boersema GC, Smart H, Giaquinto-Cilliers MGC, Mulder M, Weir GR, Bruwer FA, et al. Management of nonhealable and maintenance wounds: A systematic integrative review and referral pathway. Adv Skin Wound Care. 2021;34(1):11–22. Tottoli EM, Dorati R, Genta I, Chiesa E, Pisani S, Conti B.; Skin Wound Healing Process and New Emerging Technologies for Skin Wound Care and Regeneration. Pharmaceutics 2020, Vol 12, Page 735. el 5 de agosto de 2020;12(8):735. Faust E, Opoku-Agyeman JL, Behnam AB. Use of Negative-Pressure Wound Therapy With Instillation and Dwell Time: An Overview. Plast Reconstr Surg. el 1 de enero de 2021;147(1 1):16S-26S.; Wolvos TA. Negative pressure wound therapy with instillation: the current state of the art. Surg Technol Int. el 1 de marzo de 2014;24:53–62. Crumley C. Single-Use Negative Pressure Wound Therapy Devices: A Technologic Analysis. Journal of Wound, Ostomy and Continence Nursing. el 1 de mayo de 2021;48(3):195–8.; Kim PJ, Christopher %7C, Attinger E, Constantine %7C Thomas, Crist BD, Faust E, et al. Negative pressure wound therapy with instillation: International consensus guidelines update. Int Wound J. 2020;17:174–86. Wu M, Ruan J, Zhong B. [Progress in human epidermal growth factor research].; Sheng Wu Gong Cheng Xue Bao. el 25 de diciembre de 2020;36(12):2813–23. . Umar AK, Sriwidodo S, Maksum IP, Wathoni N. Film-Forming Spray of Water Soluble Chitosan Containing Liposome-Coated Human Epidermal Growth Factor for Wound Healing. Molecules. el 1 de septiembre de 2021;26(17).; Berlanga-Acosta J, Camacho-Rodríguez H, Mendoza-Marí Y, Falcón-Cama V, Garciá-Ojalvo A, Herrera-Martínez L, et al. Epidermal Growth Factor in Healing Diabetic Foot Ulcers: From Gene Expression to Tissue Healing and Systemic Biomarker Circulation. MEDICC Rev. el 31 de julio de 2020;22(3):24–31.; Park KH, Han SH, Hong JP, Han SK, Lee DH, Kim BS, et al. Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: A phase III multicenter, double-blind, randomized, placebo-controlled trial. Diabetes Res Clin Pract. el 1 de agosto de 2018;142:335–44.; Li S, Liu Y, Huang Z, Kou Y, Hu A. Efficacy and safety of nano-silver dressings combined with recombinant human epidermal growth factor for deep seconddegree burns: A meta-analysis. Burns. el 1 de mayo de 2021;47(3):643–53. Yip WL. Influence of oxygen on wound healing. Int Wound J. 2015;12(6):620–4. Kimmel HM, Grant A, Ditata J. The Presence of Oxygen in Wound Healing. Wounds. 2016;28(8):264–70.; Younis I. Role of oxygen in wound healing. J Wound Care. 2020;29(Sup5b):S4– 10.; Kranke P, Bennett MH, Martyn-St James M, Schnabel A, Debus SE, Weibel S. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev. el 24 de junio de 2015;2015(6):CD004123–CD004123.; Frykberg RG. Topical wound oxygen therapy in the treatment of chronic diabetic foot ulcers. Medicina (Lithuania). el 1 de septiembre de 2021;57(9). Ji S, Liu X, Huang J, Bao J, Chen Z, Han C, et al. Consensus on the application of negative pressure wound therapy of diabetic foot wounds. Burns Trauma [Internet]. el 1 de enero de 2021 [citado el 7 de octubre de 2023];9:18. Disponible en: https://dx.doi.org/10.1093/burnst/tkab018Test; Janssen AHJ, Wegdam JA, De Vries Reilingh TS, Eskes AM, Vermeulen H. Negative pressure wound therapy for patients with hard-to-heal wounds: a systematic review. J Wound Care. el 11 de abril de 2020;29(4):206–12. Wynn M, Freeman S. The efficacy of negative pressure wound therapy for diabetic foot ulcers: A systematised review. J Tissue Viability. el 1 de agosto de 2019;28(3):152–60.; Maranna H, Lal P, Mishra A, Bains L, Sawant G, Bhatia R, et al. Negative pressure wound therapy in grade 1 and 2 diabetic foot ulcers: A randomized controlled study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. el 1 de enero de 2021;15(1):365–71.; Frykberg RG. Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers. Medicina (B Aires). el 1 de septiembre de 2021;57(9). Singh D, Siddique HR. Role of Growth Factors in the Treatment of Diabetic Foot Ulceration. Diabetic Foot Ulcer. 2021;233–49.; Kaufman H, Gurevich M, Tamir E, Keren E, Alexander L, Hayes P. Topical oxygen therapy stimulates healing in difficult, chronic wounds: a tertiary centre experience. J Wound Care. el 17 de julio de 2018;27(7):426–33.; Carter MJ, Frykberg RG, Oropallo A, Sen CK, Armstrong DG, Nair HK, et al. Efficacy of Topical Wound Oxygen Therapy in Healing Chronic Diabetic Foot Ulcers: Systematic Review and Meta-Analysis. Wound. el 21 de junio de 2022; Serena TE, Bullock NM, Cole W, Lantis J, Li L, Moore S, et al. Topical oxygen therapy in the treatment of diabetic foot ulcers: a multicentre, open, randomised controlled clinical trial. J Wound Care. el 12 de mayo de 2021;30:S7–14.; He S, Liang C, Yi C, Wu M. Therapeutic effect of continuous diffusion of oxygen therapy combined with traditional moist wound dressing therapy in the treatment of diabetic foot ulcers. Diabetes Res Clin Pract. el 1 de abril de 2021;174. Tang TY, Mak MYQ, Yap CJQ, Boey JEC, Chan SL, Soon SXY, et al. An Observational Clinical Trial Examining the Effect of Topical Oxygen Therapy (NatroxTM) on the Rates of Healing of Chronic Diabetic Foot Ulcers (OTONAL Trial). Int J Low Extrem Wounds. el 6 de noviembre de 2021;15347346211053694.; Thanigaimani S, Singh T, Golledge J. Topical oxygen therapy for diabetes-related foot ulcers: A systematic review and meta-analysis. Diabetic Medicine. el 1 de agosto de 2021;38(8):e14585.; Cetinkaya OA, Celik SU, Boztug CY, Uncu H. Treatment of hard-to-heal leg ulcers with hyaluronic acid, sodium alginate and negative pressure wound therapy. J Wound Care. el 2 de julio de 2020;29(7):419–23.; Driver VR, Reyzelman A, Kawalec J, French M. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers. Ostomy Wound Manage. el 1 de abril de 2017;63(4):12–28; Frykberg RG, Franks PJ, Edmonds M, Brantley JN, Téot L, Wild T, et al. A Multinational, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy of Cyclical Topical Wound Oxygen (TWO2) Therapy in the Treatment of Chronic Diabetic Foot Ulcers: The TWO2 Study. Diabetes Care. el 1 de marzo de 2020;43(3):616–24.; Niederauer MQ, Michalek JE, Liu Q, Papas KK, Lavery LA, Armstrong DG. Continuous diffusion of oxygen improves diabetic foot ulcer healing when compared with a placebo control: a randomised, double-blind, multicentre study. J Wound Care. el 12 de septiembre de 2018;27:S30–45.; Gomez-Villa R, Aguilar-Rebolledo F, Lozano-Platonoff A, Teran-Soto JM, Fabian-Victoriano MR, Kresch-Tronik NS, et al. Efficacy of intralesional recombinant human epidermal growth factor in diabetic foot ulcers in Mexican patients: A randomized double-blinded controlled trial. Wound Repair and Regeneration. el 1 de julio de 2014;22(4):497–503.; Fernández-Montequín JI, Valenzuela-Silva CM, Díaz OG, Savigne W, SanchoSoutelo N, Rivero-Fernández F, et al. Intra-lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo-controlled, double-blind study. Int Wound J. el 1 de diciembre de 2009;6(6):432–43.; Petrou S, Parker B, Masters J, Achten J, Bruce J, Lamb SE, et al. Costeffectiveness of negative-pressure wound therapy in adults with severe open fractures of the lower limb: evidence from the WOLLF randomized controlled trial. Bone Joint J. 2019;101-B(11):1392–401; Saramago P, Claxton K, Welton NJ, Soares M. Bayesian econometric modelling of observational data for cost-effectiveness analysis: establishing the value of negative pressure wound therapy in the healing of open surgical wounds. J R Stat Soc Ser A Stat Soc. el 1 de octubre de 2020;183(4):1575–93.; C-F Chan B, Campbell KE, -Toronto K. An economic evaluation examining the cost-effectiveness of continuous diffusion of oxygen therapy for individuals with diabetic foot ulcers. Int Wound J. 2020;17:1791.; Romero Prada M, Roa C, Alfonso P, Acero G, Huérfano L, Vivas-Consuelo D. Cost-effectiveness analysis of the human recombinant epidermal growth factor in the management of patients with diabetic foot ulcers. https://doi.org/101080/2000625X20181480249Test. el 1 de enero de 2018;9(1).; Webster J, Liu Z, Norman G, Jc D. Negative pressure wound therapy for surgical wounds healing by primary closure (Review). 2019; Iheozor-Ejiofor Z, Newton K, Dumville JC, Costa ML, Norman G, Bruce J. Negative pressure wound therapy for open traumatic wounds. Cochrane Database Syst Rev. el 3 de julio de 2018;7(7).; Sethi A, Khambhayta Y, Vas P. Topical oxygen therapy for healing diabetic foot ulcers: A systematic review and meta-analysis of randomised control trials. Health Sciences Review. el 1 de junio de 2022;3:100028.; Yang Q, Zhang Y, Yin H, Lu Y. Topical Recombinant Human Epidermal Growth Factor for Diabetic Foot Ulcers: A Meta-Analysis of Randomized Controlled Clinical Trials. Ann Vasc Surg. el 1 de enero de 2020;62:442–51.; Cacua Sánchez MT. Use of Human Recombinant Epidermal Growth Factor in Chronic Wounds: Experience in Colombia-Review Article. International Journal of Innovative Studies in Medical Sciences. 2020; Edge R, Frey N. Continuously Diffused Oxygen Therapy for Wound Healing: A Review of the Clinical Effectiveness, Cost-Effectiveness, and Guidelines. 2020; Liu Z, Peinemann F. Negative pressure wound therapy for treating foot wounds in people with diabetes mellitus (Review). 2018; Lentsck MH, Baratieri T, Trincaus MR, Mattei AP, Miyahara CTS. Quality of life related to clinical aspects in people with chronic wound. Revista da Escola de Enfermagem da USP. el 3 de diciembre de 2018;52.; Santos VLC de G, Oliveira A dos S, Amaral AF dos S, Nishi ET, Junqueira JB, Kim SHP. Quality of life in patients with chronic wounds: Magnitude of changes and predictive factors. Revista da Escola de Enfermagem. 2017;51.; Naiara Vogt T, Koller FJ, Dias Santos PN, Lenhani BE, Bittencourt Guimarães PR, Kalinke LP, et al. Quality of life assessment in chronic wound patients using the Wound-QoL and FLQA-Wk instruments. Invest Educ Enferm. el 9 de noviembre de 2020;38(3):1–12.; Canadian Agency for Drugs and Technologies in Health. Optimal Care of Chronic, Non-Healing, Lower Extremity Wounds: A Review of Clinical Evidence and Guidelines. Optimal Care of Chronic, Non-Healing, Lower Extremity Wounds: A Review of Clinical Evidence and Guidelines. el 17 de diciembre de 2013; Richmond NA, Maderal AD, Vivas AC. Evidence-based management of common chronic lower extremity ulcers. Dermatol Ther. el 1 de mayo de 2013;26(3):187– 96.; Eriksson E, Liu PY, Schultz GS, Martins-Green MM, Tanaka R, Weir D, et al. Chronic wounds: Treatment consensus. Wound Repair and Regeneration. el 1 de marzo de 2022;30(2):156–71. Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford university press; 2015. Instituto de Evaluación Tecnológica en Salud. Manual para la elaboración de evaluaciones económicas en salud. 1a ed. Moreno Viscaya M, Mejia Mejia A, Castro Jaramillo HE, editores. Bogotá: Instituto de Evaluación Tecnológica en Salud - IETS; Bertram MY, Lauer JA, De Joncheere K, Edejer T, Hutubessy R, Kieny MP, et al. Cost–effectiveness thresholds: pros and cons. Bull World Health Organ. el 12 de diciembre de 2016;94(12):925.; Shillcutt SD, Walker DG, Goodman CA, Mills AJ. Cost Effectiveness in Low- and Middle-Income Countries. PharmacoEconomics 2009 27:11. el 17 de septiembre de 2012;27(11):903–17.; Espinosa O, Rodríguez-Lesmes P, Orozco L, Ávila Di, Enríquez H, Romano G, et al. Estimating cost-effectiveness thresholds under a managed healthcare system: experiences from Colombia. Health Policy Plan. el 4 de marzo de 2022;37(3):359– 68.; Sachs JD, Kennedy JF. Macroeconomics and Health: Investing in Health for Economic Development. Geneva; 2001 oct.; https://hdl.handle.net/11323/10632Test; Corporación Universidad de la Costa; REDICUC - Repositorio CUC; https://repositorio.cuc.edu.coTest |
| الإتاحة: | https://doi.org/10.1093/burnst/tkab018Test https://hdl.handle.net/11323/10632Test https://repositorio.cuc.edu.coTest |
| حقوق: | Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0) ; https://creativecommons.org/licenses/by-nc-nd/4.0Test/ ; info:eu-repo/semantics/openAccess ; http://purl.org/coar/access_right/c_abf2Test |
| رقم الانضمام: | edsbas.65DB5BD5 |
| قاعدة البيانات: | BASE |
| الوصف غير متاح. |